logo
Share SHARE
FONT-SIZE Plus   Neg

Quest Diagnostics To Sell HemoCue Diagnostic Products Business For $300 Mln

Quest Diagnostics (DGX), a provider of diagnostic information services, Monday said it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for around $300 million plus customary adjustments for cash balances.

HemoCue develops, produces and markets hemoglobin, glucose and other point-of-care testing systems worldwide.

Steve Rusckowski, President and CEO of Quest Diagnostics, said, "The HemoCue divestiture, along with our sale of OralDNA in December 2012, demonstrates our commitment to refocus our business on diagnostic information services."

Quest plans to use the proceeds to repurchase around $300 million of its shares as part of its stock buyback program.

The transaction is expected to be completed in March.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The best companies make employees feel comfortable, safe and valued at their workplace. Corporate culture develops organically over time from the cumulative traits of the people hired by the company. It is a combination of values, goals and vision of an organization that dictates the way people work.... Starbucks will close all its 379 Teavana stores over the coming year, with the coffee giant saying that the stores have been "persistently underperforming." The move will impact about 3,300 employees. The company made the announcement while reporting its third-quarter financial results on Thursday. Wal-Mart Stores has disappointed Nintendo fans after it cancelled pre-orders for the Super Nintendo Entertainment System - Classic Edition, a standalone mini Super Nintendo with pre-loaded games. The console is slated to be launched later this fall.
comments powered by Disqus
Follow RTT